Pulmonx Operating Margin 2019-2025 | LUNG
Current and historical operating margin for Pulmonx (LUNG) over the last 10 years. The current operating profit margin for Pulmonx as of March 31, 2025 is -62.88%.
| Pulmonx Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.09B | $-0.06B | -65.91% |
| 2024-12-31 | $0.08B | $-0.06B | -69.05% |
| 2024-09-30 | $0.08B | $-0.06B | -74.68% |
| 2024-06-30 | $0.08B | $-0.06B | -77.92% |
| 2024-03-31 | $0.07B | $-0.06B | -82.19% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -95.38% |
| 2023-06-30 | $0.06B | $-0.06B | -100.00% |
| 2023-03-31 | $0.06B | $-0.06B | -101.72% |
| 2022-12-31 | $0.05B | $-0.06B | -109.26% |
| 2022-09-30 | $0.05B | $-0.06B | -105.66% |
| 2022-06-30 | $0.05B | $-0.05B | -100.00% |
| 2022-03-31 | $0.05B | $-0.05B | -102.00% |
| 2021-12-31 | $0.05B | $-0.05B | -97.92% |
| 2021-09-30 | $0.04B | $-0.04B | -100.00% |
| 2021-06-30 | $0.04B | $-0.04B | -92.86% |
| 2021-03-31 | $0.03B | $-0.04B | -111.76% |
| 2020-12-31 | $0.03B | $-0.03B | -94.12% |
| 2020-06-30 | $0.02B | $-0.02B | -100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.066B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.188B | 58.76 |
| Hims & Hers Health (HIMS) | United States | $11.445B | 94.68 |
| Doximity (DOCS) | United States | $10.918B | 50.55 |
| Tempus AI (TEM) | United States | $9.613B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.013B | 0.00 |
| Hinge Health (HNGE) | United States | $4.724B | 0.00 |
| Privia Health (PRVA) | United States | $2.412B | 164.83 |
| Inspire Medical Systems (INSP) | United States | $2.320B | 34.11 |
| Phreesia (PHR) | United States | $1.613B | 0.00 |
| 10x Genomics (TXG) | United States | $1.559B | 0.00 |
| Enovis (ENOV) | United States | $1.471B | 8.20 |
| Omnicell (OMCL) | United States | $1.456B | 27.51 |
| Schrodinger (SDGR) | United States | $1.419B | 0.00 |
| Azenta (AZTA) | United States | $1.300B | 56.80 |
| Clover Health Investments (CLOV) | United States | $1.150B | 0.00 |
| Evolent Health (EVH) | United States | $1.105B | 94.10 |
| Claritev (CTEV) | United States | $0.841B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.633B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Talkspace (TALK) | United States | $0.403B | 120.50 |
| Zepp Health (ZEPP) | Netherlands | $0.367B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.341B | 0.00 |
| Carlsmed (CARL) | $0.321B | 0.00 | |
| TruBridge (TBRG) | United States | $0.320B | 711.00 |
| Health Catalyst (HCAT) | United States | $0.266B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.247B | 0.00 |
| Outset Medical (OM) | United States | $0.233B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.213B | 0.00 |
| CapsoVision (CV) | United States | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.123B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.90 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.087B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.076B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |